Biography
Fuad Fares has completed his D.Sc studies at the Faculty of Medicine, Technion-Israel Institute of Technology, and postdoctoral studiesat the Department of Molecular Biology and Pharmacology, School of Medicine, Washington University, St. Louis Missouri. He is the director of the Department of Molecular Genetics at Carmel Medical Center and associated professor at the Department of Human Biology, University of Haifa. He has published more than 75 papers in reputed journals and serving as a member of the Israel Council for Higher Education. He is the inventor of designing long-acting recombinant proteins and the initiator of PROLOR Biotech company
Research Interest
Molecular Endocrinology Molecular Genetics Apoptosis cancer
Biography
Dr. Alahari obtained his Bachelor of Science in Biology and Master of Science in Human Genetics from India in 1983 and 1986 respectively. His Ph.D. in Molecular Biology was awarded by Drexel University, Philadelphia in the year 1994. From 1994 to 1998, Dr. Alahari did a post-doctoral fellowship at the University of North Carolina at Chapel Hill. Since 1998, he has been a faculty member at the University of North Carolina and in 2004 joined the LSUHSC as Associate Professor of the Department of Biochemistry. During his tenure at the University of North Carolina, he discovered a novel protein that he termed, Nischarin. Dr. Alahari has published several papers describing the function of Nischarin. He has served on editorial review boards and study sections. In addition he availed visiting professorships at the University of Pennsylvania, Philadelphia and Rockefeller University, New York.
Research Interest
Biochemistry of cell adhesion The mechanism of action of Nischarin in tumor cell migration and invasion.
Biography
Wilker Ribeiro Filho is a Biologist, PhD in Medical Science, specialist in pharmaceutical technology and MBA in Business Management. He has experience in public policies for industrial development of the biotech industry, project’s management, businesses evaluation and management, innovation, building and managing triple helix teams with technical and C level participants. With the experience from lab tests to higher level management, he has interest in relearning things from bottom and up. Innovative, brings and forms new views and ideas when gathering old information with new ones, some yet to come, to improve competitiveness and results for partners, companies and other stake holders.
Research Interest
pharmaceutical technology